跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 371 条关于
“PPAR⍺”
全部
371
临床试验
203
药物
58
机构
8
资讯
102
去年
New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis
去年
PPAR-gamma Pathway Modulation Enhances NECTIN4-Targeted CAR-T Therapy for Bladder Cancer
去年
Inventiva's Lanifibranor Maintains Positive Safety Profile in Phase 3 MASH Trial
去年
FDA Grants Accelerated Approval to Ipsen's Iqirvo, First Dual PPAR Agonist for Primary Biliary Cholangitis
去年
Inventiva's Lanifibranor Shows Promise in Reversing Liver Vascular Damage in MASH Patients
去年
NASH Pipeline Shows Promise with 80+ Emerging Therapies in Development
10个月前
IQIRVO Shows Sustained Long-Term Benefits in Primary Biliary Cholangitis with Novel Fatigue Mechanism Insights
去年
Inventiva's Lanifibranor Maintains Positive Safety Profile in Phase 3 MASH Trial
去年
Lanifibranor Shows Promise in Phase 3 MASH Trial with Improved Liver Health Biomarkers
3个月前
Claret Capital Partners Commits €43M to Inventiva's €130M Financing for Pivotal MASH Phase 3 Trial
第 1 页,共 11 页
上一页
下一页